Business TechPfizer, Allergan Considering Blockbuster Merger: Combined Company Would Have $332B Market Cap Pfizer reportedly approached Allergan about a possible merger, which would create a company with a market cap of $332 billion. The takeover, if it pushes through, would be the biggest one for the year.by Aaron Mamiit
Healthy Living/WellnessUniversities And Colleges To Boost Meningitis B Vaccination effortsby Dianne Depra
Healthy Living/WellnessCDC Committee Pushes For Meningococcal Group B Vaccination For Adolescents And Young Adultsby Ted Ranosa
Healthy Living/WellnessPfizer Ibrance Breast Cancer Drug Shows Promising Results During Clinical Trialby Sumit Passary
Healthy Living/WellnessVaccine Costs in Developing Countries Too High, Many Blame GSK, Pfizerby James Maynard
Healthy Living/WellnessBetting Big on Gene Therapy: Pfizer Partners with Spark Therapeutics for Hemophilia Treatmentby Rhodi Lee
Healthy Living/WellnessPfizer drug Xalkori effective against rare lung cancer in clinical trialby Christian Bautista
Healthy Living/WellnessPfizer's breast cancer drug Palbociclib slows down tumor growth, shows hope for advanced casesby Rhodi Lee
Healthy Living/WellnessNew experimental cholesterol drug by Amgen may be better than Lipitorby Rhodi Lee